openPR Logo
Press release

The Gastrointestinal Stromal Tumor Market To Tilt Towards Digital Therapeutics

08-24-2022 05:53 PM CET | Health & Medicine

Press release from: Persistence Market Research

The Gastrointestinal Stromal Tumor Market To Tilt Towards

Persistence Market Research's exclusive forecast study on the global market for gastrointestinal stromal tumor (GIST) estimates that the treatments for such malignant cancer will bring in more than US$ 1.5 Bn revenues, globally, by the end of 2026.

The study has addressed a range of factors influencing the growth of the global gastrointestinal stromal tumor market for the assessment period, 2017-2026. From genetic changes to bad dietary lifestyles and increasing presence of adulterants in common foods, several factors are expected to fuel the demand for treatments on GISTs.

How About Looking Through The Sample Of Gastrointestinal Stromal Tumor Market Report? https://www.persistencemarketresearch.com/samples/20626

Company Profiles

Novartis AG
Sun Pharmaceutical Industries Limited
Pfizer Inc.
Bayer Aktiengesellschaft
NATCO Pharma Limited
How About Step-By-Step Insights To Gastrointestinal Stromal Tumor Market? Look Through The "Methodology" Employed! https://www.persistencemarketresearch.com/methodology/20626

While most of the drivers for the global gastrointestinal stromal tumor market are indicative of driving the incidence of this tumor, some factors are expected to represent patient attitudes and pharmaceutical outcomes.

During the forecast period, the global gastrointestinal stromal tumor market is estimated to expand robustly at a CAGR of 6.6%. Increasing developments in the research on new drug candidates for controlling the outgrowth of gastrointestinal stromal tumor cells will be factoring the market's growth to a considerable extent. Notwithstanding as one of the most common forms of cancer, the incidence rate of GIST continues to be remarkably low.

The World Health Organization states that in the US, the estimated incidence rate of gastrointestinal stromal tumor is 14.5 per million. The study projects that through 2026, North America will be observed as the largest market for gastrointestinal stromal tumor.

Increasing presence of genetic disorders in the US, robust healthcare infrastructure, availability of exclusive medical facilitates for caretaking of patients suffering from inoperable cancers will continue to drive the growth of North America's gastrointestinal stromal tumor market through 2026.

Over the forecast period, the gastrointestinal stromal tumor market in North America is anticipated to register a 6.9% CAGR, recording highest revenues. The study also estimates that Europe will be at the forefront of the global gastrointestinal stromal tumor market expansion during the forecast period.

Want To Keep A Tab On The Latest Findings In The Gastrointestinal Stromal Tumor Market? Purchase Our Gastrointestinal Stromal Tumor Market Report Now! https://www.persistencemarketresearch.com/checkout/20626

Patients to Opt for Conventional Symptomatic Treatments such as Chemotherapy

Being inoperable in nature, gastrointestinal stromal tumor has a limited treatment scope. The role of radiotherapy in gastrointestinal stromal tumor treatment remains unestablished till date. Patients seek symptomatic treatments such as chemotherapy while medical professionals await a clinical practice breakthrough.

In 2017, more than US$ 185 Mn worth of revenues were procured globally from treatment of gastrointestinal stromal tumor with chemotherapy. The study also projects that targeted drug therapy will gain traction as a viable treatment for early-stage GISTs in the foreseeable future.

Difficulties in Clearing FDA Pipeline

Currently, the competition landscape in the global gastrointestinal stromal tumor market exhibits the presence of only a handful of players. Companies namely, Sun Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., NATCO Pharma Limited, and Bayer Aktiengesellschaft are expected to remain active in expansion of the global GIST market from 2017 to 2026.

Several leading pharma companies are anticipated to penetrate the consolidated competition in the global market during the forecast period. Unable to clear the FDA approvals remains the key impediment and entry barrier in the global gastrointestinal stromal tumor market.

High End-use in Hospitals; Stomach Indication to Account for Nearly 3/5th Share of Global Revenues

Additional research findings from the report reveal that stomach is the key segment in terms of indication of GISTs. While the occurrence of gastrointestinal stromal tumor may take place in any part of the GI tract, its localization remains common in the stomach.

In 2017, stomach as an indication will account for nearly US$ 500 Mn revenues in the global market. The report also expects that hospitals will be the largest end-users in the global market, and will rake in over US$ 485 Mn revenues from treatments of GISTs by 2026-end.

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Gastrointestinal Stromal Tumor Market To Tilt Towards Digital Therapeutics here

News-ID: 2715391 • Views: 165

More Releases from Persistence Market Research

AI Powered Storage Market Drivers, End User,Top Key Players, Challenges by 2033
The global AI-powered storage market is expected to value US$ 16.8 Billion in 2021 and US$ 21.3 Billion in 2022. The market is projected to secure US$ 120 Billion in 2032, exhibiting a healthy CAGR of 18.9% from 2022 to 2032. Expansion of the market can be attributed to the increasing need for efficient storage architecture and growing data volumes. The increasing number of connected devices and the rising adoption of
Global Allergic Rhinitis Treatment Market 2023: Immunotherapy Treatment Segment …
The global allergic rhinitis treatment market is expected to witness steady growth over the forecast period due to increasing prevalence of allergic rhinitis and other respiratory allergies; combined with rising awareness towards early diagnosis and treatment of such diseases. The market can be segmented into product type, end user and region. Based on product type, the market can be divided into anti-allergy medication, immunotherapy and others. By end user, the market
Human Capital Management Hcm Market Business Strategies, Segmentation and Growth …
According to detailed Persistence Market Research analysis, demand registered in the human capital management (HCM) market is set to increase at a CAGR of 7.7% from 2022 to 2032. The report also forecasts that the market will surpass a valuation of US$ 20.5 Bn by the end of 2022. Adoption of human capital management solutions has been rising owing to increasing focus on effective workforce management practices and digitization of HR
Global Flavors into Over-the-Counter (OTC) Pharmaceuticals Market 2023: Feasibly …
The global flavors into Over-the-Counter (OTC) pharmaceuticals market is expected to witness steady growth over the forecast period due to increasing demand for OTC medications especially among children and young adults; combined with growing awareness towards the importance of flavor masking in medicine. The market can be segmented into product type, end user and region. Based on product type, the market can be divided into natural and synthetic flavors. By end

All 5 Releases


More Releases for GIST

GIST Mutation Detection Kit Market Trends, Growth Analysis, Investigation by Reg …
The QY Research released a latest market research report on the global and United States GIST Mutation Detection Kit market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global GIST Mutation Detection Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region
Current research: Water Feature Market Installed For Attached Leg Of Mass | Vert …
Report Ocean recently published a new report on the Global Water Feature Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Water Feature Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Water Feature Market situation of the leading key players, key market trends, and potential
Chatbot Builder Software Market to See Huge Growth by 2027 | Gist, MobileMonkey, …
Global Chatbot Builder Software Market Report 2021 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Chatbot Builder Software Market. Some of the key players profiled in the study are Tars, ChatBot, Gist, MobileMonkey,
YabaLeftOnline NG Presenting the Latest Naija Gist and Nigeria Entertainment New …
YabaLeftOnline NG is a leading online platform in Nigeria that offers a wide variety of news from across the country. The platform displays Naija gist, as well as viral news in Nigeria. On YabaLeftOnline NG, its readers can check out the popular Nigerian music videos, music world’s news, and comedy skits. Whether it is Banky W’s campaign posters being destroyed in Lagos or the latest about BBNaija star Anto, the
Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Report 2018
In this report, the Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with
Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Report 2018
In this report, the Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with